Skip to main content
Premium Trial:

Request an Annual Quote

Personal Genomes Project Begins Enrollment for PGP-100; Integrating Google's Personal Health Record Platform


This article was originally published March 22.

Harvard Medical School's Personal Genomes Project has started enrolling participants for the PGP-100 phase of the study, and plans to increase enrollment later this year. The project is also currently integrating the Google Health personal health-record platform.

The PGP, led by Harvard Medical School professor George Church, was launched in 2007 with 10 participants, known as PGP-10. Long-term, it aims to sequence the genomes of 100,000 individuals and correlate their genotypes with phenotypic information.

Last year, the study organizers said they were going to scale up to 100 participants, a phase dubbed PGP-100, and said that sequencing their entire genomes, rather than just their exomes, would be an "increasingly viable option" (see In Sequence 10/20/2009).

In a newsletter published last week, PGP organizers said they have now started to enroll participants for the PGP-100. Over the next several months, they plan to collect tissue samples from "as many PGP-100 participants as possible" and to start posting data from them on the project's website "shortly." They also expect to begin enrollment for the next phase of the project, PGP-1000, later this year.

Under a recently awarded research grant from Google, Church's lab will also integrate the Google Health personal health-record platform into the PGP, a project expected to be completed by this summer.

This will allow participants "to more easily and accurately share, monitor, and update their basic health data with the PGP, should they choose to do so," according to the organizers. "We're looking forward to working with the PGP participants to discover how they utilize tools like the Google Health PHR to manage their health data and, ultimately, improve their own health outcomes."

In addition, the PGP said it is going to update its consent forms and study protocols as part of an annual review of the study, based on recommendations from Harvard Medical School's Institutional Review Board and user feedback. The project is also organizing a meeting in Boston next month, called the "Genomes, Environments, Traits Conference." There, individuals who had their genomes sequenced will "share their experiences" and "discuss the important ways in which personal genomes will affect key aspects of our lives."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.